Secondary analysis of Radiation Therapy Oncology Group study (RTOG) 9310: an intergroup phase II combined modality treatment of primary central nervous system lymphoma Conference

Fisher, B, Seiferheld, W, Schultz, C et al. (2005). Secondary analysis of Radiation Therapy Oncology Group study (RTOG) 9310: an intergroup phase II combined modality treatment of primary central nervous system lymphoma . JOURNAL OF NEURO-ONCOLOGY, 74(2), 201-205. 10.1007/s11060-004-6596-9

International Collaboration

cited authors

  • Fisher, B; Seiferheld, W; Schultz, C; DeAngelis, L; Nelson, D; Schold, S; Curran, W; Mehta, M

sustainable development goals

authors

date/time interval

  • November 4, 2001 -

publication date

  • September 1, 2005

webpage

published in

keywords

  • CHEMOTHERAPY
  • Clinical Neurology
  • Life Sciences & Biomedicine
  • NON-HODGKINS-LYMPHOMA
  • Neurosciences & Neurology
  • Oncology
  • PRIMARY CNS LYMPHOMA
  • RADIOTHERAPY
  • SURVIVAL
  • Science & Technology
  • cognitive function
  • hyper-fractionation
  • neurotoxicity
  • primary CNS lymphoma
  • radiotherapy

Location

  • SAN FRANCISCO, CA

Digital Object Identifier (DOI)

Conference

  • 43rd Annual Meeting of the American-Society-for-Therapeutic-Radiology-and-Oncology

publisher

  • SPRINGER

start page

  • 201

end page

  • 205

volume

  • 74

issue

  • 2